Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Mertens

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Treatment and Research|January 1, 1993
Adjuvant chemotherapy of soft tissue sarcomasW C Mertens, V H Bramwell
Nuclear Medicine Communications|February 1, 1994
Utility of 111In-labelled leukocytes in patients completing high-dose interleukin-2 therapy: a pilot studyW C Mertens, J E Power
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapyW C Mertens, D J Grignon, W Romano
American Journal of Clinical Oncology|June 1, 1993
Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship?W C Mertens, L Stitt, A T Porter
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Adenocarcinoma of the eccrine sweat gland: response to both combination chemotherapy and local field irradiationW C Mertens, D T Shum, J A Gilchrist
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1992
Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary reportW C Mertens, A T Porter, R H Reid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, J Jolivet, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: a phase II studyW C Mertens, V H Bramwell, D Banerjee, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1985
Differential aspects of sleep epilepsyG B Young, W T Blume, G A Wells, et al.
CA: a Cancer Journal for Clinicians|December 5, 1998
Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current conceptsW C Mertens, L A Filipczak, E Ben-Josef, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Treatment and Research|January 1, 1993
Adjuvant chemotherapy of soft tissue sarcomasW C Mertens, V H Bramwell
Nuclear Medicine Communications|February 1, 1994
Utility of 111In-labelled leukocytes in patients completing high-dose interleukin-2 therapy: a pilot studyW C Mertens, J E Power
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapyW C Mertens, D J Grignon, W Romano
American Journal of Clinical Oncology|June 1, 1993
Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship?W C Mertens, L Stitt, A T Porter
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Adenocarcinoma of the eccrine sweat gland: response to both combination chemotherapy and local field irradiationW C Mertens, D T Shum, J A Gilchrist
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1992
Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary reportW C Mertens, A T Porter, R H Reid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials GroupW C Mertens, E A Eisenhauer, J Jolivet, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: a phase II studyW C Mertens, V H Bramwell, D Banerjee, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1985
Differential aspects of sleep epilepsyG B Young, W T Blume, G A Wells, et al.
CA: a Cancer Journal for Clinicians|December 5, 1998
Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current conceptsW C Mertens, L A Filipczak, E Ben-Josef, et al.
Pageof 3